197 related articles for article (PubMed ID: 28429694)
1. The rationale and design of the national familial hypercholesterolemia registries in Turkey: A-HIT1 and A-HIT2 studies.
Kayıkçıoğlu M; Tokgözoğlu L
Turk Kardiyol Dern Ars; 2017 Apr; 45(3):261-267. PubMed ID: 28429694
[TBL] [Abstract][Full Text] [Related]
2. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
Kayikcioglu M; Tokgozoglu L; Dogan V; Ceyhan C; Tuncez A; Kutlu M; Onrat E; Alici G; Akbulut M; Celik A; Yesilbursa D; Sahin T; Sonmez A; Ozdogan O; Temizhan A; Kilic S; Bayram F; Sabuncu T; Coskun FY; Ildizli M; Durakoglugil E; Kirilmaz B; Yilmaz MB; Yigit Z; Yildirim AB; Gedikli O; Topcu S; Oğuz A; Demir M; Yenerçağ M; Yıldırır A; Demircan S; Yilmaz M; Kaynar LG; Aktan M; Durmus RB; Gokce C; Ozcebe Oİ; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O; Can LH
Atherosclerosis; 2018 Oct; 277():341-346. PubMed ID: 30270069
[TBL] [Abstract][Full Text] [Related]
3. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry).
Kayikcioglu M; Tokgozoglu L; Yilmaz M; Kaynar L; Aktan M; Durmuş RB; Gokce C; Temizhan A; Ozcebe OI; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Yenercag M; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O
Atherosclerosis; 2018 Mar; 270():42-48. PubMed ID: 29407887
[TBL] [Abstract][Full Text] [Related]
4. Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry).
Kayikcioglu M; Kuman-Tunçel O; Pirildar S; Yílmaz M; Kaynar L; Aktan M; Durmuş RB; Gökçe C; Temizhan A; Özcebe OI; Akyol TK; Okutan H; Sağ S; Oz Gul O; Salcioglu Z; Yenercag M; Altunkeser BB; Kuku I; Yasar HY; Kurtoğlu E; Demir M; Demircioğlu S; Pekkolay Z; Ílhan O; Tokgozoglu L
J Clin Lipidol; 2019; 13(3):455-467. PubMed ID: 30928440
[TBL] [Abstract][Full Text] [Related]
5. [Homozygous familial hypercholesterolemia].
Kaylkçioğlu M
Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():19-31. PubMed ID: 25693360
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
[TBL] [Abstract][Full Text] [Related]
7. Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry).
Kuman Tunçel Ö; Kayıkçıoğlu M; Pırıldar Ş; Yılmaz M; Kaynar L; Aktan M; Durmuş RB; Gökçe C; Temizhan A; Özcebe Oİ; Karaağaç Akyol T; Okutan H; Sağ S; Öz Gül Ö; Yenerçağ M; Altunkeser BB; Kuku İ; Yılmaz Yaşar H; Kurtoğlu E; Demircioğlu S; Pekkolay Z; İlhan O; Tokgözoğlu L
J Clin Lipidol; 2020; 14(3):361-370.e2. PubMed ID: 32423761
[TBL] [Abstract][Full Text] [Related]
8. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
Ahmad ZS; Andersen RL; Andersen LH; O'Brien EC; Kindt I; Shrader P; Vasandani C; Newman CB; deGoma EM; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Kullo IJ; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
J Clin Lipidol; 2016; 10(5):1223-9. PubMed ID: 27678440
[TBL] [Abstract][Full Text] [Related]
9. [Long-term follow-up in patients with homozygous familial hypercholesterolemia; 13-year experience of a university hospital lipid clinic].
Kayıkçıoğlu M; Kısmalı E; Can L; Payzin S
Turk Kardiyol Dern Ars; 2014 Oct; 42(7):599-611. PubMed ID: 25490294
[TBL] [Abstract][Full Text] [Related]
10. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
[TBL] [Abstract][Full Text] [Related]
11. Awareness, treatment rates, and compliance to treatment in patients with serum LDL cholesterol higher than 250 mg/dL, and possible, probable, or definite familial hypercholesterolemia.
Yaman S; Ozdemir D; Akman BT; Cakir B; Ersoy O
Postgrad Med; 2021 Mar; 133(2):146-153. PubMed ID: 32744105
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry.
Cuchel M; Lee PC; Hudgins LC; Duell PB; Ahmad Z; Baum SJ; Linton MF; de Ferranti SD; Ballantyne CM; Larry JA; Hemphill LC; Kindt I; Gidding SS; Martin SS; Moriarty PM; Thompson PP; Underberg JA; Guyton JR; Andersen RL; Whellan DJ; Benuck I; Kane JP; Myers K; Howard W; Staszak D; Jamison A; Card MC; Bourbon M; Chora JR; Rader DJ; Knowles JW; Wilemon K; McGowan MP
J Am Heart Assoc; 2023 May; 12(9):e029175. PubMed ID: 37119068
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish National Database.
Sonmez A; Demirci I; Haymana C; Tasci I; Ayvalı MO; Ata N; Ezgu FS; Bayram F; Barcin C; Caglayan M; Ülgü MM; Birinci S; Tokgozoglu L; Satman I; Kayikcioglu M
Atherosclerosis; 2023 Jun; 375():9-20. PubMed ID: 37216728
[TBL] [Abstract][Full Text] [Related]
14. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.
; Vallejo-Vaz AJ; Akram A; Kondapally Seshasai SR; Cole D; Watts GF; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Freiberger T; Abifadel M; Aguilar-Salinas CA; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Ceska R; Corral P; Descamps O; Dieplinger H; Do CT; Durst R; Ezhov MV; Fras Z; Gaita D; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Lin N; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi H; Nilsson L; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Reiner Ž; Sahebkar A; Santos LE; Schunkert H; Shehab A; Slimane MN; Stoll M; Su TC; Susekov A; Tilney M; Tomlinson B; Tselepis AD; Vohnout B; Widén E; Yamashita S; Catapano AL; Ray KK
Atheroscler Suppl; 2016 Dec; 22():1-32. PubMed ID: 27939304
[TBL] [Abstract][Full Text] [Related]
15. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
Vishwanath R; Hemphill LC
J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
[TBL] [Abstract][Full Text] [Related]
16. Identifying undiagnosed or undertreated patients with familial hypercholesterolemia from the laboratory records of a tertiary medical center.
Haymana C; Berlik H; Güneş Y; Tunçez OE; Aytekin C; Tapıkara Z; Güzel H; Öztürk Ö; Barçın C; Özgürtaş T; Azal Ö; Sönmez A
Turk Kardiyol Dern Ars; 2017 Dec; 45(8):731-738. PubMed ID: 29226894
[TBL] [Abstract][Full Text] [Related]
17. Gaps in the Care of Subjects with Familial Hypercholesterolemia: Insights from the Thai Familial Hypercholesterolemia Registry.
Ganokroj P; Muanpetch S; Deerochanawong C; Phimphilai M; Leelawattana R; Thongtang N; Krittayaphong R; Anthanont P; Vathesatogkit P; Sriphrapradang C; Senthong V; Torpongpun A; Suteerayongprasert P; Pengpong N; Sathavarodom N; Sunanta U; Porntharukchareon T; Kiatpanabhikul P; Kaewkrasaesin C; Suraamornkul S; Kongkit J; Umphonsathien M; Chattranukulchai P; Jiamjarasrungsi W; Khovidhunkit W
J Atheroscler Thromb; 2023 Dec; 30(12):1803-1816. PubMed ID: 37197952
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction.
Rerup SA; Bang LE; Mogensen UM; Engstrøm T; Jørgensen E; Pedersen F; Torp-Pedersen C; Gislason G; James S; Hagström E; Køber L; Fosbøl EL
Am Heart J; 2016 Nov; 181():35-42. PubMed ID: 27823691
[TBL] [Abstract][Full Text] [Related]
19. The development of the Mexican Familial Hypercholesterolemia (FH) National Registry.
Mehta R; Martagon AJ; Galan Ramirez GA; Gonzalez Retana G; Martinez-Beltran M; Vargas Vazquez A; Vazquez-Cardenas A; Aguilar-Salinas CA
Atherosclerosis; 2018 Oct; 277():517-523. PubMed ID: 30270093
[TBL] [Abstract][Full Text] [Related]
20. Comparative aspects of the care of familial hypercholesterolemia in the "Ten Countries Study".
Pang J; Chan DC; Hu M; Muir LA; Kwok S; Charng MJ; Florkowski CM; George PM; Lin J; Loi DD; Marais AD; Nawawi HM; Gonzalez-Santos LE; Su TC; Truong TH; Santos RD; Soran H; Tomlinson B; Yamashita S; Ademi Z; Watts GF
J Clin Lipidol; 2019; 13(2):287-300. PubMed ID: 30797720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]